Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

807

Participants

Timeline

Start Date

October 10, 2017

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Smoking Cessation
Interventions
BEHAVIORAL

Motivational Interviewing (MI)

two counseling sessions

DRUG

Nicotine Replacement Therapy (NRT)

receive 6 weeks of NRT patch with dosing dependent upon reported baseline cigarettes per day

DRUG

Nicotine Lozenge

6 packs of NRT 2mg lozenge

BEHAVIORAL

Message Framing

health communication literature and quitting messages

OTHER

saliva sample

saliva samples from those reporting abstinence and analyze samples

Trial Locations (18)

10065

Memorial Sloan Kettering Cancer Center, New York

Weill Cornell Medical Center, New York

10467

Montefiore Medical Center (Data Collection Only), The Bronx

11501

NYU Winthrop Hospital, Mineola

19140

Temple University, Philadelphia

28655

Carolinas Healthcare System Blue Ridge, Morganton

30240

WellStar Health System, La Grange

43130

Fairfield Medical Center, Lancaster

46307

St. Mary Medical Center, Community Healthcare System, Crown Point

48202

Henry Ford Hospital (Data collection only), Detroit

49684

Munson Healthcare, Traverse City

50314

MercyOne Des Moines Medical Center (Data Collection Only), Des Moines

60901

Riverside Healthcare, Kankakee

90033

University of Southern California (Data Collection Only), Los Angeles

94598

John Muir Health, Walnut Creek

97210

Legacy Health, Portland

606012

Rush University Medical Center, Chicago

04074

Maine Medical Center Cancer Institute, Scarborough

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER